Literature DB >> 26153486

Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot Study.

Amit Khairnar1, Peter Latta2, Eva Drazanova3,4, Jana Ruda-Kucerova5,4, Nikoletta Szabó6, Anas Arab5,4, Birgit Hutter-Paier7, Daniel Havas7, Manfred Windisch8, Alexandra Sulcova5, Zenon Starcuk2,3, Irena Rektorova9.   

Abstract

Evidence suggests that accumulation and aggregation of α-synuclein contribute to the pathogenesis of Parkinson's disease (PD). The aim of this study was to evaluate whether diffusion kurtosis imaging (DKI) will provide a sensitive tool for differentiating between α-synuclein-overexpressing transgenic mouse model of PD (TNWT-61) and wild-type (WT) littermates. This experiment was designed as a proof-of-concept study and forms a part of a complex protocol and ongoing translational research. Nine-month-old TNWT-61 mice and age-matched WT littermates underwent behavioral tests to monitor motor impairment and MRI scanning using 9.4 Tesla system in vivo. Tract-based spatial statistics (TBSS) and the DKI protocol were used to compare the whole brain white matter of TNWT-61 and WT mice. In addition, region of interest (ROI) analysis was performed in gray matter regions such as substantia nigra, striatum, hippocampus, sensorimotor cortex, and thalamus known to show higher accumulation of α-synuclein. For the ROI analysis, both DKI (6 b-values) protocol and conventional (2 b-values) diffusion tensor imaging (cDTI) protocol were used. TNWT-61 mice showed significant impairment of motor coordination. With the DKI protocol, mean, axial, and radial kurtosis were found to be significantly elevated, whereas mean and radial diffusivity were decreased in the TNWT-61 group compared to that in the WT controls with both TBSS and ROI analysis. With the cDTI protocol, the ROI analysis showed decrease in all diffusivity parameters in TNWT-61 mice. The current study provides evidence that DKI by providing both kurtosis and diffusivity parameters gives unique information that is complementary to cDTI for in vivo detection of pathological changes that underlie PD-like symptomatology in TNWT-61 mouse model of PD. This result is a crucial step in search for a candidate diagnostic biomarker with translational potential and relevance for human studies.

Entities:  

Keywords:  Diffusion kurtosis imaging; Parkinson’s disease; TBSS; TNWT-61; Transgenic mice; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 26153486     DOI: 10.1007/s12640-015-9537-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  41 in total

1.  Stratification of heterogeneous diffusion MRI ischemic lesion with kurtosis imaging: evaluation of mean diffusion and kurtosis MRI mismatch in an animal model of transient focal ischemia.

Authors:  Jerry S Cheung; Enfeng Wang; Eng H Lo; Phillip Zhe Sun
Journal:  Stroke       Date:  2012-07-05       Impact factor: 7.914

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

Review 3.  Milestones in Parkinson's disease therapeutics.

Authors:  Olivier Rascol; Andres Lozano; Matthew Stern; Werner Poewe
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

4.  Diffusion kurtosis and diffusion-tensor MR imaging in Parkinson disease.

Authors:  Marco Giannelli; Nicola Toschi; Luca Passamonti; Mario Mascalchi; Stefano Diciotti; Carlo Tessa
Journal:  Radiology       Date:  2012-11       Impact factor: 11.105

5.  Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging.

Authors:  Jens H Jensen; Joseph A Helpern; Anita Ramani; Hanzhang Lu; Kyle Kaczynski
Journal:  Magn Reson Med       Date:  2005-06       Impact factor: 4.668

Review 6.  Genetic mouse models of parkinsonism: strengths and limitations.

Authors:  Sheila M Fleming; Pierre-Olivier Fernagut; Marie-Françoise Chesselet
Journal:  NeuroRx       Date:  2005-07

7.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

Authors:  Sheila M Fleming; Jonathan Salcedo; Pierre-Olivier Fernagut; Edward Rockenstein; Eliezer Masliah; Michael S Levine; Marie-Françoise Chesselet
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

8.  Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.

Authors:  Maria F Falangola; David N Guilfoyle; Ali Tabesh; Edward S Hui; Xingju Nie; Jens H Jensen; Scott V Gerum; Caixia Hu; John LaFrancois; Heather R Collins; Joseph A Helpern
Journal:  NMR Biomed       Date:  2014-06-03       Impact factor: 4.044

9.  Lack of tryptophan hydroxylase-1 in mice results in gait abnormalities.

Authors:  Georgette L Suidan; Daniel Duerschmied; Gregory M Dillon; Veronique Vanderhorst; Thomas G Hampton; Siu Ling Wong; Jaymie R Voorhees; Denisa D Wagner
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.

Authors:  Stefan T Schwarz; Maryam Abaei; Vamsi Gontu; Paul S Morgan; Nin Bajaj; Dorothee P Auer
Journal:  Neuroimage Clin       Date:  2013-10-14       Impact factor: 4.881

View more
  6 in total

1.  Diffusion Kurtosis Imaging as a Tool in Neurotoxicology.

Authors:  Brian Hansen
Journal:  Neurotox Res       Date:  2019-08-17       Impact factor: 3.911

2.  Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging.

Authors:  Koji Kamagata; Andrew Zalesky; Taku Hatano; Ryo Ueda; Maria Angelique Di Biase; Ayami Okuzumi; Keigo Shimoji; Masaaki Hori; Karen Caeyenberghs; Christos Pantelis; Nobutaka Hattori; Shigeki Aoki
Journal:  Hum Brain Mapp       Date:  2017-05-04       Impact factor: 5.038

3.  Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.

Authors:  Anas Arab; Jana Ruda-Kucerova; Alzbeta Minsterova; Eva Drazanova; Nikoletta Szabó; Zenon Starcuk; Irena Rektorova; Amit Khairnar
Journal:  Neurotox Res       Date:  2019-06-18       Impact factor: 3.911

4.  Microstructural white matter alterations in Alzheimer's disease and amnestic mild cognitive impairment and its diagnostic value based on diffusion kurtosis imaging: a tract-based spatial statistics study.

Authors:  Tongtong Li; Yu Zhang; Xiuwei Fu; Xianchang Zhang; Yuan Luo; Hongyan Ni
Journal:  Brain Imaging Behav       Date:  2021-04-24       Impact factor: 3.978

5.  Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.

Authors:  Tuva R Hope; Per Selnes; Irena Rektorová; Lubomira Anderkova; Nela Nemcova-Elfmarkova; Zuzana Balážová; Anders Dale; Atle Bjørnerud; Tormod Fladby
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

6.  Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.

Authors:  Lin Yang; Yan Cheng; Yongyan Sun; Yinghua Xuan; Jianping Niu; Jitian Guan; Yunjie Rong; Yanlong Jia; Zerui Zhuang; Gen Yan; Renhua Wu
Journal:  Front Aging Neurosci       Date:  2022-03-15       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.